BeStock  
Stocks › Biotechnology › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2295Biotechnology
$73.01 −$4.66 (-6.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $71.00 -2.75%
Open$77.09
Prev close$77.67
Day range$72.57 – $78.11
Volume706.8K
Market cap$3.60B
P/E (TTM)–
Dividend yield–

TARS Stock News

Headlines matching Tarsus Pharmaceuticals or the TARS ticker, most recent first.

  • Jefferies Initiates Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Announces Target Price $105Market news · 9 Sep 2026 · Direct mention
  • Goldman Sachs Upgrades Tarsus Pharmaceuticals(TARS.US) to Buy Rating, Raises Target Price to $116 PositiveMarket news · 24 Sep 2026 · Direct mention
  • Barclays Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $110 PositiveMarket news · 17 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $104Market news · 8 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $104 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $100 PositiveMarket news · 7 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $88Market news · 7 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $98Market news · 4 Aug 2026 · Direct mention
  • William Blair Maintains Tarsus Pharmaceuticals(TARS.US) With Buy RatingMarket news · 12 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $100Market news · 12 Aug 2026 · Direct mention
  • Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $100 PositiveMarket news · 12 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Tarsus Pharmaceuticals(TARS.US), With a Forecast Between $88 to $100Market news · 9 Jul 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Prime Medicine, Inc. (PRME) and Ascendis Pharma (ASND)TipRanks · 9 Jul 2026 · Direct mention
  • Mizuho Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Cuts Target Price to $98 NegativeMarket news · 31 Jul 2026 · Direct mention
  • Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Cuts Target Price to $89 NegativeMarket news · 22 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TARS.

Sign in to join the discussion.

Scroll to Top